Deadly new Covid variant sweeps across Europe—are we heading for another lockdown?

Deadly new Covid variant sweeps across Europe—are we heading for another lockdown?

A fresh wave of Covid-19 concern has swept across Europe as a new variant, known as XEC, gains ground, showing signs of becoming the dominant strain. First detected in Germany in June 2024, the XEC variant is now spreading rapidly across several countries, including the United Kingdom, Denmark, and the Netherlands, prompting health experts to […]

Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India

Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India

The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the Omicron-specific mRNA-based booster vaccine, developed by Pune-based Gennova Biopharmaceuticals, has received Emergency Use Authorization (EUA) from the Drug Control General of India (DCGI). This significant development has been facilitated through the Mission COVID Suraksha initiative, managed by […]

Everest Medicines commissions mRNA vaccine production plant in Jiashan

Everest Medicines commissions mRNA vaccine production plant in Jiashan

Everest Medicines, a China-based biopharmaceutical company, has commenced operations at its mRNA vaccine production plant in Jiashan, Zhejiang Province, thereby becoming a fully-integrated biopharma. With the first phase going live, Everest Medicines now owns complete pharmaceutical and vaccine value chain from discovery, clinical development, manufacturing, and commercialization. The first phase of the vaccine manufacturing facility […]

FDA grants EUA for Omicron-adapted Covid-19 vaccine for children below five

FDA grants EUA for Omicron-adapted Covid-19 vaccine for children below five

Pfizer and BioNTech have received the US Food and Drug Administration (FDA) emergency use authorization (EUA) for their Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine for children aged six months to four years. The shot is authorized as the third 3-µg dose in the three-dose primary series. Albert Bourla — Pfizer Chairman and CEO said: “This authorization […]

Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19

Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19

Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of mild-to-moderate Covid-19. According to Lilly, bebtelovimab is a neutralizing IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2, which has also shown capability to neutralize against the Omicron […]

Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy

Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy

Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to carry out a global phase 3 clinical trial of an inhaled Covid-19 antibody cocktail therapy made up of regdanvimab (CT-P59) and CT-P63. The late-stage clinical trial will assess the efficacy and safety of the cocktail therapy in […]

Regeneron says REGEN-COV monoclonal antibodies active against Omicron, Delta and other variants

Regeneron says REGEN-COV monoclonal antibodies active against Omicron, Delta and other variants

Regeneron Pharmaceuticals said that the monoclonal antibodies of its REGEN-COV cocktail are active against all known variants of concern of Covid-19, including Omicron and Delta. According to the US biotech company, REGEN-COV, which comprises the casirivimab and imdevimab antibodies, has diminished potency against Omicron, but is active against the Delta variant, which is more prevailing […]